Friedrich von Bohlen, Christoph Mutter, Jan Traenckner, Jrgen Dormann, Klaus Pohle, Richard Roy, Claire Fraser, Steven Salzberg | GenomeWeb

Lion Bioscience last week appointed Friedrich von Bohlen, Christoph Mutter, and Jan Traenckner to its new supervisory board. The three replace J rgen Dormann, Klaus Pohle, and Richard Roy, who resigned from the supervisory board in October. Von Bohlen, who will serve as chairman, was formerly CEO of Lion and also serves as chairman of the board of Private Life BioMed in Frankfurt, Germany, and is on the board of Oncoscore in Basel, Switzerland.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.